• ABOUT JSLR
• DIRECTORS AND COMMITTEES
• SECRETARIAT AND MEMBERSHIP

• AIMS AND SCOPE
• ONLINE SUBMISSION
• ARTICLE TYPES
• MANUSCRIPT PREPARATION
• EDITORIAL PROCESS
• POST-ACCEPTANCE
  　　AND TECHNICAL INFORMATION
• EDITORIAL POLICIES
• OPEN ACCESS AND COPYRIGHT
• ADVERTISING POLICY
• CONTACT INFORMATION
• ARCHIVES
• EDITORIAL BOARD

OFFICIAL JOURNAL OF THE JSLR > ARCHIVES > Volume 59, Number 2

• Volume 59(2019), No. 2 , Released: June 2019

  ■Commentary

  Highlights: Focus on immunodeficiency-associated lymphoproliferative disorders
  Current topics on other iatrogenic immunodeficiency-associated lymphoproliferative disorders and EBV-positive mucocutaneous ulcer

  Yasuharu Sato

  ■Review Articles

  Iatrogenic immunodeficiency-associated lymphoproliferative disorders of B-cell type that develop in patients receiving immunosuppressive drugs other than in the post-transplant setting

  Shuji Momose and Jun-ichi Tamaru

  Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders with a T- or NK-cell phenotype

  Akira Satou, Toyonori Tsuzuki and Shigeo Nakamura

  A review of EBV-positive mucocutaneous ulcers focusing on clinical and pathological aspects

  Tomoka Ikeda, Yuka Gion, Tadashi Yoshino, Yasuharu Sato

  Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders

  Michihide Tokuhira, Jun-ichi Tamaru, and Masahiro Kizaki

  ■Letter to the Editors

  DLBCL developed into fatal liver failure during rituximabcontaining chemotherapy

  Yutaka Shimazu and Masaharu Nohgawa

  Spontaneous remission of acute monocytic leukemia with trisomy 8 and trisomy 18

  Takahiro Suyama, Kaoru Hasebe

  Final analysis of a phase II study of ibrutinib in Japanese patients with relapsed/refractory mantle cell lymphoma

  Dai Maruyama, Hirokazu Nagai, Noriko Fukuhara, Toshiyuki Kitano, Takayuki Ishikawa
  Tomoaki Nishikawa